Compare Cognizant Technology Solutions Corp (CTSH) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cognizant Technology Solutions Corp vs Mesoblast Limited — how do they compare? Cognizant Technology Solutions Corp trades at $57.84 (market cap $26.40B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Cognizant Technology Solutions Corp is far larger — about 11.9× Mesoblast Limited's market cap, and Cognizant Technology Solutions Corp pays a 2.25% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| CTSH | MESO | |
|---|---|---|
Market Cap | $26.40B | $2.21B |
Sector | Technology | Technology |
52-Week High | $86.70 | $20.96 |
52-Week Low | $38.73 | $12.88 |
Enterprise Value | $27.44B | $2.21B |
Dividend Yield | 2.25% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cognizant Technology Solutions Corp
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
